Comparison of Solitaire to Embotrap to Treat Large Vessel Occlusion in Acute Ischemic Stroke (SOLTRAP Study)

NCT05518240 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 418

Last updated 2022-08-26

No results posted yet for this study

Summary

The primary aim of this study is to assess if there is a difference in first pass reperfusion between the two devices. This is a randomized prospective study to assess if there is a difference in first pass reperfusion at two centers with large mechanical thrombectomy volumes. Data will also be collected on time-to treatment, outcomes and hemorrhagic complications.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

Stent Retrievers

Procedure: Embotrap device

DEVICE

Stent Retriever

Procedure: Solitaire device

Sponsors & Collaborators

  • WellStar Health System

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-24
Primary Completion
2024-08-07
Completion
2025-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05518240 on ClinicalTrials.gov